ABBV
Price
$192.45
Change
-$2.55 (-1.31%)
Updated
Jul 11 closing price
Capitalization
322.43B
19 days until earnings call
BMY
Price
$46.86
Change
-$1.66 (-3.42%)
Updated
Jul 11 closing price
Capitalization
109.66B
19 days until earnings call
Interact to see
Advertisement

ABBV vs BMY

Header iconABBV vs BMY Comparison
Open Charts ABBV vs BMYBanner chart's image
ABBVIE
Price$192.45
Change-$2.55 (-1.31%)
Volume$4.99M
Capitalization322.43B
Bristol-Myers Squibb
Price$46.86
Change-$1.66 (-3.42%)
Volume$13.72M
Capitalization109.66B
ABBV vs BMY Comparison Chart in %
Loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABBV vs. BMY commentary
Jul 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a Buy and BMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 12, 2025
Stock price -- (ABBV: $192.45 vs. BMY: $46.86)
Brand notoriety: ABBV and BMY are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 77% vs. BMY: 103%
Market capitalization -- ABBV: $322.43B vs. BMY: $109.66B
ABBV [@Pharmaceuticals: Major] is valued at $322.43B. BMY’s [@Pharmaceuticals: Major] market capitalization is $109.66B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 4 FA rating(s) are green whileBMY’s FA Score has 2 green FA rating(s).

  • ABBV’s FA Score: 4 green, 1 red.
  • BMY’s FA Score: 2 green, 3 red.
According to our system of comparison, ABBV is a better buy in the long-term than BMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 7 TA indicator(s) are bullish while BMY’s TA Score has 4 bullish TA indicator(s).

  • ABBV’s TA Score: 7 bullish, 3 bearish.
  • BMY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABBV is a better buy in the short-term than BMY.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а +1.67% price change this week, while BMY (@Pharmaceuticals: Major) price change was -0.13% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.82%. For the same industry, the average monthly price growth was +0.32%, and the average quarterly price growth was +10.27%.

Reported Earning Dates

ABBV is expected to report earnings on Oct 24, 2025.

BMY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.82% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABBV($322B) has a higher market cap than BMY($110B). ABBV has higher P/E ratio than BMY: ABBV (66.46) vs BMY (13.73). ABBV YTD gains are higher at: 10.332 vs. BMY (-14.211). BMY has higher annual earnings (EBITDA): 19.4B vs. ABBV (17.2B). ABBV (12.8B) and BMY (12.3B) have equal amount of cash in the bank . BMY has less debt than ABBV: BMY (41.5B) vs ABBV (59.4B). ABBV has higher revenues than BMY: ABBV (54.3B) vs BMY (45B).
ABBVBMYABBV / BMY
Capitalization322B110B293%
EBITDA17.2B19.4B89%
Gain YTD10.332-14.211-73%
P/E Ratio66.4613.73484%
Revenue54.3B45B121%
Total Cash12.8B12.3B104%
Total Debt59.4B41.5B143%
FUNDAMENTALS RATINGS
ABBV vs BMY: Fundamental Ratings
ABBV
BMY
OUTLOOK RATING
1..100
5959
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
1194
SMR RATING
1..100
1430
PRICE GROWTH RATING
1..100
2759
P/E GROWTH RATING
1..100
1459
SEASONALITY SCORE
1..100
865

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMY's Valuation (5) in the Pharmaceuticals Major industry is significantly better than the same rating for ABBV (86). This means that BMY’s stock grew significantly faster than ABBV’s over the last 12 months.

ABBV's Profit vs Risk Rating (11) in the Pharmaceuticals Major industry is significantly better than the same rating for BMY (94). This means that ABBV’s stock grew significantly faster than BMY’s over the last 12 months.

ABBV's SMR Rating (14) in the Pharmaceuticals Major industry is in the same range as BMY (30). This means that ABBV’s stock grew similarly to BMY’s over the last 12 months.

ABBV's Price Growth Rating (27) in the Pharmaceuticals Major industry is in the same range as BMY (59). This means that ABBV’s stock grew similarly to BMY’s over the last 12 months.

ABBV's P/E Growth Rating (14) in the Pharmaceuticals Major industry is somewhat better than the same rating for BMY (59). This means that ABBV’s stock grew somewhat faster than BMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVBMY
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
45%
Bearish Trend 1 day ago
52%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
48%
MACD
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
56%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
60%
Bearish Trend 1 day ago
52%
Advances
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
55%
Declines
ODDS (%)
Bearish Trend 5 days ago
46%
Bearish Trend 5 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
59%
Aroon
ODDS (%)
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARCM100.28N/A
N/A
Arrow Reserve Capital Management ETF
EFU10.68N/A
-0.01%
ProShares UltraShort MSCI EAFE
THYF52.21-0.09
-0.17%
T. Rowe Price U.S. High Yield ETF
PRFD50.73-0.14
-0.28%
PIMCO Preferred and Cp Sec Act Exc-Trd
MTUM236.25-1.36
-0.57%
iShares MSCI USA Momentum Factor ETF

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
-1.31%
PFE - ABBV
54%
Loosely correlated
-0.50%
AMGN - ABBV
50%
Loosely correlated
-1.70%
NVS - ABBV
46%
Loosely correlated
-2.19%
JNJ - ABBV
44%
Loosely correlated
-0.50%
GILD - ABBV
42%
Loosely correlated
-4.28%
More